.png)
Phase 2 Research Study
Research Study for Adults with
Bipolar Depression
Help researchers evaluate an investigational medication for symptoms of depression and anhedonia associated with Bipolar I or II.
See If You QualifyLocal Study
Austin, Texas
Duration
6-Week Participation
Visits
In-Person Clinic
Ages
18–65 Years
About the Study
Advancing options for mood management.
Community Clinical Research is conducting a Phase 2 study to evaluate the efficacy and safety of an investigational medication, Icalcaprant.
This research focuses on adults experiencing a depressive episode associated with Bipolar I or II disorder to understand if the investigational drug can help manage symptoms of depression and anhedonia.
What to Expect
Medical care and psychiatric monitoring
Initial Phase
Comprehensive psychiatric screening including ECG and blood work.
The Study
6 weeks of investigational medication or placebo alongside your current mood stabilizer.
Who Can Participate?
- Adults aged 18 to 65
- Bipolar I or II diagnosis
- Experiencing a depressive episode
- Stable on Lithium, Valproate, or Lamotrigine
.png)
Benefits & Compensation
Up to $1,275 for time and travel.
Qualified participants receive all study-related medical exams, lab tests, and investigational medication at no cost. Compensation is available up to $1,275 for your time and travel.
Join a Bipolar depression
research study today
Help us evaluate new adjunctive treatment options in Austin, TX.
See If You QualifyFrequently Asked Questions
This research evaluates the safety and effectiveness of an investigational drug, Icalcaprant, for Bipolar I or II depression when used alongside stable mood stabilizers.
No, participants must remain on a stable dose of one approved mood stabilizer (Lithium, Valproate, or Lamotrigine) throughout the duration of the study.
Yes. All information collected is kept strictly confidential in accordance with HIPAA and privacy regulations.
